Establishment Labs (ESTA) Competitors $31.47 +0.15 (+0.48%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$30.00 -1.47 (-4.67%) As of 04:56 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ESTA vs. SLNO, IRTC, PRCT, NVST, TMDX, LIVN, ENOV, NVCR, LMAT, and CNMDShould you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), Envista (NVST), TransMedics Group (TMDX), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), LeMaitre Vascular (LMAT), and CONMED (CNMD). These companies are all part of the "medical equipment" industry. Establishment Labs vs. Soleno Therapeutics iRhythm Technologies PROCEPT BioRobotics Envista TransMedics Group LivaNova Enovis NovoCure LeMaitre Vascular CONMED Establishment Labs (NASDAQ:ESTA) and Soleno Therapeutics (NASDAQ:SLNO) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, community ranking, valuation, earnings, institutional ownership and dividends. Which has more volatility and risk, ESTA or SLNO? Establishment Labs has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Comparatively, Soleno Therapeutics has a beta of -2.29, meaning that its stock price is 329% less volatile than the S&P 500. Is ESTA or SLNO more profitable? Soleno Therapeutics has a net margin of 0.00% compared to Establishment Labs' net margin of -46.13%. Soleno Therapeutics' return on equity of -61.99% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets Establishment Labs-46.13% -184.55% -24.81% Soleno Therapeutics N/A -61.99%-55.21% Do analysts rate ESTA or SLNO? Establishment Labs presently has a consensus price target of $57.40, indicating a potential upside of 82.40%. Soleno Therapeutics has a consensus price target of $99.63, indicating a potential upside of 41.81%. Given Establishment Labs' higher probable upside, equities research analysts plainly believe Establishment Labs is more favorable than Soleno Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Establishment Labs 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.67Soleno Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.22 Which has better valuation & earnings, ESTA or SLNO? Soleno Therapeutics has lower revenue, but higher earnings than Establishment Labs. Soleno Therapeutics is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEstablishment Labs$166.03M5.47-$78.50M-$2.98-10.56Soleno TherapeuticsN/AN/A-$38.99M-$4.26-16.49 Does the MarketBeat Community believe in ESTA or SLNO? Soleno Therapeutics received 201 more outperform votes than Establishment Labs when rated by MarketBeat users. Likewise, 72.56% of users gave Soleno Therapeutics an outperform vote while only 61.98% of users gave Establishment Labs an outperform vote. CompanyUnderperformOutperformEstablishment LabsOutperform Votes11961.98% Underperform Votes7338.02% Soleno TherapeuticsOutperform Votes32072.56% Underperform Votes12127.44% Do institutionals and insiders believe in ESTA or SLNO? 72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 97.4% of Soleno Therapeutics shares are held by institutional investors. 11.4% of Establishment Labs shares are held by insiders. Comparatively, 12.3% of Soleno Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media refer more to ESTA or SLNO? In the previous week, Soleno Therapeutics had 1 more articles in the media than Establishment Labs. MarketBeat recorded 13 mentions for Soleno Therapeutics and 12 mentions for Establishment Labs. Soleno Therapeutics' average media sentiment score of 1.07 beat Establishment Labs' score of 0.85 indicating that Soleno Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 1 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Soleno Therapeutics 6 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummarySoleno Therapeutics beats Establishment Labs on 12 of the 18 factors compared between the two stocks. Remove Ads Get Establishment Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ESTA vs. The Competition Export to ExcelMetricEstablishment LabsSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$907.78M$8.61B$5.33B$7.57BDividend YieldN/A1.71%5.11%4.32%P/E Ratio-12.2018.5321.6617.82Price / Sales5.4770.45373.3994.61Price / CashN/A19.6738.1534.64Price / Book44.324.856.474.00Net Income-$78.50M$284.66M$3.20B$247.23M7 Day Performance-8.84%0.22%2.86%1.45%1 Month Performance-15.04%-1.67%-8.56%-6.24%1 Year Performance-39.18%-21.42%10.58%0.60% Establishment Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ESTAEstablishment Labs2.1777 of 5 stars$31.47+0.5%$57.40+82.4%-38.3%$907.78M$166.03M-12.20960Analyst ForecastNews CoveragePositive NewsGap DownSLNOSoleno Therapeutics4.7834 of 5 stars$69.64+3.2%$99.63+43.1%+82.4%$3.19BN/A-20.9830Analyst ForecastGap DownHigh Trading VolumeIRTCiRhythm Technologies0.9178 of 5 stars$100.17-0.2%$119.73+19.5%-8.0%$3.15B$591.84M-27.521,790Positive NewsPRCTPROCEPT BioRobotics2.3992 of 5 stars$50.83-0.8%$94.29+85.5%+4.6%$2.79B$224.50M-26.07430Positive NewsGap DownHigh Trading VolumeNVSTEnvista4.3811 of 5 stars$15.27-1.4%$20.18+32.2%-21.0%$2.63B$2.51B-2.3512,700Analyst ForecastAnalyst RevisionNews CoveragePositive NewsGap DownTMDXTransMedics Group2.7684 of 5 stars$69.15+2.2%$122.70+77.4%-5.1%$2.33B$441.54M73.56210LIVNLivaNova3.561 of 5 stars$35.40-1.5%$61.17+72.8%-34.8%$1.92B$1.25B84.292,900Positive NewsHigh Trading VolumeENOVEnovis2.2227 of 5 stars$32.41-0.4%$58.50+80.5%-44.7%$1.85B$2.11B-14.806,800NVCRNovoCure3.335 of 5 stars$16.61+0.7%$35.80+115.5%+29.4%$1.83B$605.22M-11.861,320LMATLeMaitre Vascular3.0974 of 5 stars$79.39-0.5%$95.25+20.0%+31.3%$1.79B$219.86M43.38490Positive NewsHigh Trading VolumeCNMDCONMED4.7109 of 5 stars$55.34-1.6%$77.20+39.5%-35.5%$1.71B$1.31B13.054,100 Remove Ads Related Companies and Tools Related Companies Soleno Therapeutics Alternatives iRhythm Technologies Alternatives PROCEPT BioRobotics Alternatives Envista Alternatives TransMedics Group Alternatives LivaNova Alternatives Enovis Alternatives NovoCure Alternatives LeMaitre Vascular Alternatives CONMED Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ESTA) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredRadical shift coming to the stock market (read this ASAP)This is an urgent warning for all American investors … In a matter of days, we could see a radical shift in...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Establishment Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ESTA Stock Free ESTA Stock Alerts